Avantor Investor Day Presentation Deck

2025 Target: Attractive organic growth profile ~$7.2B- 7.4B REVENUE 2021E¹ Navantor™ Biopharma HSD BASE BUSINESS GROWTH Education & Gov't LSD B Healthcare MSD AT/AM MSD ORGANIC GROWTH DRIVERS $ APPROACHING $10B BY 2025 1. 2021E reflects FY21 Q2 earnings call guidance range, excluding pending M&A 2025E based on organic growth and excludes pending and potential future M&A 2. 4-6% LONG TERM GROWTH $1.5-2.0B REVENUE² -$9.0B- 9.5B REVENUE 2025E² ORGANIC $ GROWTH 76

View entire presentation